Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2006-05-30
2010-12-28
Zara, Jane (Department: 1635)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C435S006120, C435S091310, C514S04400A, C536S023100, C536S024320
Reexamination Certificate
active
07858770
ABSTRACT:
The present invention relates to an siRNA (small interfering RNA) having antiviral activity against nonpolio enteroviruses, and a pharmaceutical composition comprising same as an active ingredient for preventing and treating diseases caused by nonpolio enterovirus infection.
REFERENCES:
patent: 2002/0142293 (2002-10-01), Crainic et al.
patent: WO 02/103060 (2002-12-01), None
Norder, H. et al., J. Gen'l. Virol., vol. 83, pp. 1721-1728 (2002).
Reynolds, A. et al., Nature, Biotech., vol. 22, No. 3, pp. 326-330 (2004).
Grist, N.R. et al., Enteroviruses in Human Disease, Porg. Med. Virol., v.24, pp. 114-157 (1978).
Muir, P., “Enteroviruses and heart disease,” Br. J. Biomed. Sci., v.50, pp. 258-271 (1993).
Rotbart, H.A., “Enteroviral Infections of the Central Nervous System,” Clin. Infect. Dis., v.20, pp. 971-981 (1995).
Dykxhoorn, E.M. et al., “Killing the Messenger: Short RNAs That Silence Gene Expression,” Nat. Rev. Mol. Cell. Biol., v.4, pp. 457-467 (2005).
Fire, A. et al., “Potent and specific genetic interference by double-stranded RNA inCaenorhabditis elgans,” Nature, v.391, pp. 806-811 (1998).
Elbashir, S.M. et al., “Duplexes of 21-nucleotide RNAs mediate RNAs interference in cultured mammalian cells,” Nature, v.411, pp. 494-498 (2001).
Zamore, P.D. et al., “RNAi: Double-Stranded RNA Directs the ATP-Dependent Cleavage of MRNA at 21 to 23 Nucleotide Intervals,” Cell, v.101, pp. 25-33 (2000).
Bernstein, E. et al., “The Rest is Silence,” RNA, v.7, pp. 1509-1521 (2001).
Hasuwa, H. et al., “Small interfering RNA and gene silencing in transgenic mice and rats,” FEBS LETT., v.532, pp. 227-230 (2002).
Dave, R.S. et al., “RNA interference: on the road to an alternate therapeutic strategy!,” Rev. Med. Virol., v.13, pp. 373-385 (2003).
Stevenson, M., “Dissecting HIV-1 Through RNA Interference,” Nat. Rev. Immunol., v.3, pp. 851-858, 2003.
Ahn, J. et al., “Characteristics of Apoptotic Cell Death Induced by Coxsackievirus B in Permissive Vero Cells,” Intervirology, v.46, pp. 245-251, 2003.
Merl, S. et al., “Targeting 2A protease by RNA interference attenuates coxsackieviral cytopathogenicity and promotes survival in highly susceptible mice,” Circulation, v.111(13), pp. 1583-1592, 2005.
Schubert, S. et al., “Maintaining Inhibition: siRNA Double Expression Vectors Against Coxsackieviral RNAs,” J. Mol. Biol., v.346, pp. 457-465, 2005.
Yuan, J. et al., “Inhibition of coxsackievirus B3 replication by small interfering RNAs requires perfect sequence match in the central region of the viral positive strand,” J. Virol., v.79(4), pp. 2151-2159, 2005.
van Regenmortel, M.H.V. et al., Taxonomic Structure of the Family, Virus Taxonomy, Academic Press, pp. 657-664, 2000.
Gitlin, L. et al., “Short interfering RNA confers intracellular antiviral immunity in human cells,” Nature, v.418, pp. 430-434, 2002.
Gitlin, L. et al., “Poliovirus Escape from RNA Interference: Short Interfering RNA-Target Recognition and Implications for Therapeutic Approaches,” J. Virol., v.79, pp. 1027-1035, 2005.
Graham, F.L. et al., “A New Technique for the Assay of Infectivity of Human Adenovirus 5 DNA,” Virol., 52, pp. 456-467, 1973.
McCutchan, J.H. et al., “Enhancement of the Infectivity of Simian Virus 40 Deoxyribonucleic Acid with Diethyl-aminoethyl-Dextran,” J. Natl. Cancer Inst., 41, pp. 351-357, 1968.
Chu, G. et al., “Electroporation for the efficient transfection of mammalian cells with DNA,” Nucl. Acids Res., 15, 1311-1326, 1987.
Fraley, R. et al., “Introduction of Liposome-encapsulated SV40 DNA into Cells,” J. Biol. Chem., 255, pp. 10431-10435, 1980.
Capecchi, M.R. et al., “High Efficiency Transformation by Direct Microinjection of DNA into Cultured Mammalian Cells,” Cell, 22, pp. 479-488, 1980.
Felgner, P.L. et al., “Lipofection: A highly efficient, lipid-mediated DNA-transfection procedure,” Proc. Nati. Acad. Sci. USA, 84, pp. 7413-7417, 1987.
Ahn, J. et al., “A small interfering RNA targeting coxsackievirus B3 protects permissive HeLa cells from viral challenge,” J. of Virol., v.79(13), pp. 8620-8624, 2005.
Ahn Jeonghyun
Kim Yoo Kyum
Lee Heuiran
Lee Hui Sun
Brooks & Kushman P.C.
University of Ulsan Foundation for Industry Cooperation
Zara Jane
LandOfFree
siRNA having antiviral activity against nonpolio enterovirus does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with siRNA having antiviral activity against nonpolio enterovirus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and siRNA having antiviral activity against nonpolio enterovirus will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4194134